153 related articles for article (PubMed ID: 2057055)
1. Impaired metabolic activation in Alzheimer's disease: a PET study during continuous visual recognition.
Kessler J; Herholz K; Grond M; Heiss WD
Neuropsychologia; 1991; 29(3):229-43. PubMed ID: 2057055
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities of energy metabolism in Alzheimer's disease studied with PET.
Heiss WD; Szelies B; Kessler J; Herholz K
Ann N Y Acad Sci; 1991; 640():65-71. PubMed ID: 1776760
[TBL] [Abstract][Full Text] [Related]
3. Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type.
Mielke R; Herholz K; Grond M; Kessler J; Heiss WD
Neurobiol Aging; 1992; 13(1):93-8. PubMed ID: 1542386
[TBL] [Abstract][Full Text] [Related]
4. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern.
Mielke R; Pietrzyk U; Jacobs A; Fink GR; Ichimiya A; Kessler J; Herholz K; Heiss WD
Eur J Nucl Med; 1994 Oct; 21(10):1052-60. PubMed ID: 7828614
[TBL] [Abstract][Full Text] [Related]
5. Dysfunction of visual cortex contributes to disturbed processing of visual information in Alzheimer's disease.
Mielke R; Kessler J; Fink G; Herholz K; Heiss WD
Int J Neurosci; 1995 May; 82(1-2):1-9. PubMed ID: 7591506
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography for diagnosis of Alzheimer's disease and vascular dementia.
Mielke R; Heiss WD
J Neural Transm Suppl; 1998; 53():237-50. PubMed ID: 9700661
[TBL] [Abstract][Full Text] [Related]
7. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
Pietrini P; Furey ML; Graff-Radford N; Freo U; Alexander GE; Grady CL; Dani A; Mentis MJ; Schapiro MB
Am J Psychiatry; 1996 Oct; 153(10):1261-8. PubMed ID: 8831432
[TBL] [Abstract][Full Text] [Related]
8. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
Vander Borght T; Minoshima S; Giordani B; Foster NL; Frey KA; Berent S; Albin RL; Koeppe RA; Kuhl DE
J Nucl Med; 1997 May; 38(5):797-802. PubMed ID: 9170449
[TBL] [Abstract][Full Text] [Related]
9. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
Pietrini P; Dani A; Furey ML; Alexander GE; Freo U; Grady CL; Mentis MJ; Mangot D; Simon EW; Horwitz B; Haxby JV; Schapiro MB
Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390
[TBL] [Abstract][Full Text] [Related]
10. Regional cerebral glucose transport and utilization in Alzheimer's disease.
Friedland RP; Jagust WJ; Huesman RH; Koss E; Knittel B; Mathis CA; Ober BA; Mazoyer BM; Budinger TF
Neurology; 1989 Nov; 39(11):1427-34. PubMed ID: 2812318
[TBL] [Abstract][Full Text] [Related]
11. FDG PET and differential diagnosis of dementia.
Herholz K
Alzheimer Dis Assoc Disord; 1995; 9(1):6-16. PubMed ID: 7605624
[TBL] [Abstract][Full Text] [Related]
12. Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: implications for brain reserve.
Mosconi L; Herholz K; Prohovnik I; Nacmias B; De Cristofaro MT; Fayyaz M; Bracco L; Sorbi S; Pupi A
J Neurol Neurosurg Psychiatry; 2005 Jan; 76(1):15-23. PubMed ID: 15607989
[TBL] [Abstract][Full Text] [Related]
13. The functional neuroanatomy of verbal memory in Alzheimer's disease: [
Staffaroni AM; Melrose RJ; Leskin LP; Riskin-Jones H; Harwood D; Mandelkern M; Sultzer DL
J Clin Exp Neuropsychol; 2017 Sep; 39(7):682-693. PubMed ID: 27876444
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography in Alzheimer's disease.
Duara R; Grady C; Haxby J; Sundaram M; Cutler NR; Heston L; Moore A; Schlageter N; Larson S; Rapoport SI
Neurology; 1986 Jul; 36(7):879-87. PubMed ID: 3487046
[TBL] [Abstract][Full Text] [Related]
16. Activation in the premotor cortex during mental calculation in patients with Alzheimer's disease: relevance of reduction in posterior cingulate metabolism.
Ouchi Y; Yoshikawa E; Futatsubashi M; Okada H; Torizuka T; Kaneko M
Neuroimage; 2004 May; 22(1):155-63. PubMed ID: 15110005
[TBL] [Abstract][Full Text] [Related]
17. Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter.
DeCarli C; Grady CL; Clark CM; Katz DA; Brady DR; Murphy DG; Haxby JV; Salerno JA; Gillette JA; Gonzalez-Aviles A; Rapoport SI
J Neurol Neurosurg Psychiatry; 1996 Feb; 60(2):158-67. PubMed ID: 8708645
[TBL] [Abstract][Full Text] [Related]
18. P300 in Alzheimer's disease: relationships to dementia severity and glucose metabolism.
Szelies B; Mielke R; Grond M; Heiss WD
J Neurol Sci; 1995 May; 130(1):77-81. PubMed ID: 7650534
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
McGeer PL; Kamo H; Harrop R; Li DK; Tuokko H; McGeer EG; Adam MJ; Ammann W; Beattie BL; Calne DB
CMAJ; 1986 Mar; 134(6):597-607. PubMed ID: 3512063
[TBL] [Abstract][Full Text] [Related]
20. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.
Piert M; Koeppe RA; Giordani B; Berent S; Kuhl DE
J Nucl Med; 1996 Feb; 37(2):201-8. PubMed ID: 8667045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
